Article Information
vol. 4 no. 41
- Received October 8, 2018
- Accepted October 24, 2019
- .
Author Information
- Melissa S. F. Ng1,2,
- Theodore L. Roth1,3,4,
- Ventura F. Mendoza5,
- Alexander Marson3,4,6,7,8,9,10 and
- Trevor D. Burt5,11,*,†
- 1Biomedical Sciences Graduate Program, University of California, San Francisco (UCSF), San Francisco, CA 94143, USA.
- 2Singapore Immunology Network, Agency for Science, Technology and Research, Biopolis, Singapore 138648, Singapore.
- 3Department of Microbiology and Immunology, UCSF, San Francisco, CA 94143, USA.
- 4Diabetes Center, UCSF, San Francisco, CA 94143, USA.
- 5Eli and Edythe Broad Center of Regeneration Medicine and Stem Cell Research, UCSF, San Francisco, CA 94143, USA.
- 6Innovative Genomics Institute, University of California, Berkeley, CA 94720, USA.
- 7Department of Medicine, UCSF, San Francisco, CA 94143, USA.
- 8Chan Zuckerberg Biohub, San Francisco, CA 94158, USA.
- 9UCSF Helen Diller Family Comprehensive Cancer Center, UCSF, San Francisco, CA 94158, USA.
- 10Parker Institute for Cancer Immunotherapy, San Francisco, CA 94129, USA.
- 11Department of Pediatrics, Division of Neonatology, UCSF, San Francisco, CA 94110, USA.
- ↵*Corresponding author. Email: trevor.burt{at}duke.edu